ArticleComputational biology and chemistry2007
A mathematical analysis of SELEX.
Article in Computational biology and chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Are we there yet with XNA aptamers?RSC advances · 2026Review
- Progress in Aptamer Research and Future Applications.ChemistryOpen · 2025Review
- Article
- Pyoverdine binding aptamers and label-free electrochemical detection of pseudomonads.Frontiers in chemistry · 2024Article
- Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing.International journal of molecular sciences · 2023Article
- Affinity-based isolation of extracellular vesicles and the effects on downstream molecular analysis.Analytical and bioanalytical chemistry · 2022Review
- Discrete stochastic models of SELEX: Aptamer capture probabilities and protocol optimization.The Journal of chemical physics · 2022Article
- Advances and Challenges in Small-Molecule DNA Aptamer Isolation, Characterization, and Sensor Development.Angewandte Chemie (International ed. in English) · 2021Review
- Inside the Black Box: What Makes SELEX Better?Molecules (Basel, Switzerland) · 2019Review
- In vitro isolation of class-specific oligonucleotide-based small-molecule receptors.Nucleic acids research · 2019Article
- A 2'FY-RNA Motif Defines an Aptamer for Ebolavirus Secreted Protein.Scientific reports · 2018Article
- Microfluidic methods for aptamer selection and characterization.The Analyst · 2017Review
- A statistical framework for analyzing deep mutational scanning data.Genome biology · 2017Article
- The Genetic Code and RNA-Amino Acid Affinities.Life (Basel, Switzerland) · 2017Review
- Transcription factor family-specific DNA shape readout revealed by quantitative specificity models.Molecular systems biology · 2017Article
- Controlling uncertainty in aptamer selection.Proceedings of the National Academy of Sciences of the United States of America · 2016Article
- Aptamers in analytics.The Analyst · 2016Review
- Article
- SELEX-seq: a method for characterizing the complete repertoire of binding site preferences for transcription factor complexes.Methods in molecular biology (Clifton, N.J.) · 2014Article
- Aptamers as both drugs and drug-carriers.BioMed research international · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Systematic evolution of ligands by exponential enrichment (SELEX) is a procedure by which a mixture of nucleic acids that vary in sequence can be separated into pure components with the goal of isolating those with specific biochemical activities. The basic idea is to combine the mixture with a specific target molecule and then separate the target-NA complex from the resulting reaction. The target-NA complex is then separated by mechanical means (for example by filtration), the NA is then eluted from the complex, amplified by polymerase chain reaction (PCR) and the process repeated. After several rounds, one should be left with a pool of [NA] that consists mostly of the species in the original pool that best binds to the target. In Irvine et al. [Irvine, D., Tuerk, C., Gold, L., 1991. SELEXION, systematic evolution of nucleic acids by exponential enrichment with integrated optimization by non-linear analysis. J. Mol. Biol. 222, 739-761] a mathematical analysis of this process was given. In this paper we revisit Irvine et al. [Ibid]. By rewriting the equations for the SELEX process, we considerably reduce the labor of computing the round to round distribution of nucleic acid fractions. We also establish necessary and sufficient conditions for the SELEX process to converge to a pool consisting solely of the best binding nucleic acid to a fixed target in a manner that maximizes the percentage of bound target. The assumption is that there is a single nucleic acid binding site on the target that permits occupation by not more than one nucleic acid. We analyze the case for which there is no background loss (no support losses and no free [NA] left on the support). We then examine the case in which such there are such losses. The significance of the analysis is that it suggests an experimental approach for the SELEX process as defined in Irvine et al. [Ibid] to converge to a pool consisting of a single best binding nucleic acid without recourse to any a priori information about the nature of the binding constants or the distribution of the individual nucleic acid fragments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.